Choroidal Neovascularization
99
3
5
61
Key Insights
Highlights
Success Rate
82% trial completion
Published Results
20 trials with published results (20%)
Research Maturity
61 completed trials (62% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
13.1%
13 terminated out of 99 trials
82.4%
-4.1% vs benchmark
23%
23 trials in Phase 3/4
33%
20 of 61 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 61 completed trials
Clinical Trials (99)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
Long Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular Neovascularization
Effect of Video Viewing on Intravitreal Injection Experience
Biomarkers and Choroidal Neovascularization
An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings
Efficacy and Safety of RTH258 Versus Aflibercept - Study 1
Efficacy and Safety of RTH258 Versus Aflibercept - Study 2
Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia
Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks
Efficacy of Retreatments With Intravitreal Bevacizumab
Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment
Study on the Biomarkers of Anti-VEGF Treatment for Choroidal Neovascularization
Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV
Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMD
Effect of Corona Virus on Intravitreal Injections
Safety, Tolerability and Pharmacokinetic Profile of SYL1801 Eye Drops
Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study
OCTA Insights in CNVM, Morphological Characteristics and Correlation With Structural OCT.